Spark Biomedical News

Neurostimulation Clinical Trial Shows Promising Initial Results in Easing Opioid Withdrawal Symptoms in NewbornsRead MoreRead More
Spark Biomedical takes “Best in Show” at 2020 NANSRead MoreRead More
Spark Biomedical Presents and Exhibits at the North American Neuromodulation Society 23rd Annual ConferenceRead MoreRead More
Spark Biomedical Launches Clinical Trial to Treat Opioid WithdrawalRead MoreRead More
Spark Biomedical Receives $217K NIH Grant to Help Opioid-Addicted NewbornsRead MoreRead More
Texas A&M alumnus’ biomedical company wins 2019 Texas A&M New Ventures CompetitionRead MoreRead More
Houston Based Galen Data and Spark Biomedical Reach AgreementRead MoreRead More
Spark Biomedical, Inc Semi-Finalist in Texas A&M New Ventures CompetitionRead MoreRead More